Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced new dermatology data presented at the European Academy of Dermatology and Venereology (EADV) ...

Pharmaceutical companies are making investments in research of therapies that target three different antigen-binding sites. Trispecific antibody research is still in its earliest phases and is focused ...

Do you foresee IV and subQ route of administration always having a role moving forward? How do you see the treatment landscape changing?

Subsequent entry biologics, follow-on biologics, biosimilars or similar biotherapeutic products. What's in a name? They all refer to products which are subsequent to and similar to an innovator or ...

Is the UK’s NHS saving enough from the new wave of biosimilars? These new competitors to blockbuster biologics medicines promise to save money for healthcare systems, and create ‘headroom ...

After hours: September 23 at 7:29 PM EDT Loading Chart for ADMA ...

Part 2 of our series diving into the Association for Accessible Medicines' (AAM) latest report discusses that while generics and biosimilars saved $445 billion in 2023, their potential is hindered by ...

China Biologic Products, Inc. operates as a biopharmaceutical company, which engages in the manufacture and distribution of plasma-based pharmaceutical products and other biological substances.

You’re hopeful, yet nervous, and sometimes even a little impatient. When your rheumatologist prescribed a biologic to help control your ankylosing spondylitis pain, you probably thought ...